Postpartum Period In Dairy Cows Research Articles

Update on ketosis in dairy cattle with major emphasis on subclinical ketosis and abdominal adiposity.

The metabolic changes that occur during the early post-partum period in dairy cows can indeed lead to an imbalance in energy utilization, resulting in the production of excessive ketone bodies. This can have detrimental effects on the cow's health and milk production, leading to economic losses for dairy producers. The release of non-esterified fatty acids into the blood due to increased lipolysis is a key factor in the development of ketosis. Abdominal adiposity is a key factor on these outcomes in modern dairy cows. The redirection of energy and glucose towards lactose synthesis and milk yield leaves a deficit of gluconeogenic precursors, leading to the conversion of acetyl-CoA into ketone bodies instead of entering the Krebs cycle. These ketone bodies, including acetone, acetoacetate and β-hydroxybutyrate, accumulate in the blood and can be detected in various bodily fluids, such as urine, blood and milk, allowing for diagnostic testing. Prevention is indeed crucial in managing ketosis in dairy cattle. Supplementation of propylene glycol in the diet or the use of monensin, either in the diet or in the form of a slow-release bolus, can help prevent the occurrence of ketosis. However, avoiding high body condition (subcutaneous fat) and excessive abdominal adiposity during the dry period and parturition plus an adequate cow comfort are fundamental tasks to avoid ketosis and related disorders. These interventions aim to provide additional energy sources or enhance the cow's ability to utilize energy efficiently, thus reducing the reliance on excessive lipolysis and ketone body production.

Efectos de la suplementación con acacia negra (Acacia mearnsii) sobre la actividad ovárica, la involución uterina y los perfiles hormonales en vacas lecheras en condiciones de altura

The feeding program carried out during the pre-partum and post-partum period in dairy cows is crucial to preserve their reproductive performance. The goal of the present study was to assess the effect of black wattle (Acacia mearnsii) supplementation on ovarian activity, uterine involution, and hormone profiles in dairy cows maintained at high-altitude conditions. A total of 10 Holstein dairy cows were divided into 2 groups: control (C; n=5) and supplemented group (AM; n=5). A dehydrated black wattle (AM; Acacia mearnsii) supplement was administered to AM group and adjusted to 22% crude protein per animal (Dehydrated Supplement; MS= 2.7 kg AM/day per cow, ~20% of total DM). Body weight (BW) was recorded individually in different periods (day 15 pre-partum, and day 19, 34, and 49 post-partum). Ovarian [follicles (FL), corpora lutea (CL)] and ovarian diameter (OD; mm)] and uterine structures [uterine horn thickness (HT; mm), cervix length (CrL; cm) and diameter (CD; cm), and uterine involution %] were assessed till day 34 postpartum. Moreover, hormone profiles such as thyroid-stimulating hormone (TSH; IU/mL), follicle-stimulating hormone (FSH; IU/mL), luteinizing hormone (LH; IU/mL), and progesterone (P4; ng/mL) were measured till day 49. Statistical differences were observed in BW when day 15 prepartum was compared to day 19 postpartum (p=0.05). However, no differences were observed between C and AM group regarding BW within each timepoint (p>0.05). No changes were observed in FL over time irrespective of the group studied (p<0.05). However, FL was significantly different when C and AM group were compared within each time-point (p< 0.05). Although no significant differences were observed on day 5 post- partum regarding the number of CL, significant differences were observed on day 25 and day 34 postpartum between groups (p> 0.05). OD increased from day 5 to Day 35 post-partum irrespective of the group assessed and differ between groups within time-points (p< 0.05). Differences were observed in TSH within day 19 and day 49 post-partum (p< 0.05). FSH was statistically different between groups on day 19 post-partum (p< 0.05). LH was more variable than TSH and FSH among and within time-points and groups (p< 0.05). Differences were observed between groups regarding P4 within day 19 and 49 post-partum (p< 0.05). In conclusion, overall although no differences were observed in BW between groups or time-points, the supplementation with AM showed differential patterns in reproductive tract structures/dimensions and hormone levels in dairy cows maintained at high-altitude conditions

Effects of Intrauterine Infusion of Micronised Purified Flavonoid Fraction (MPFF) in Metritis-Diagnosed Dairy Cows Naturally Infected by E. coli during the Early Postpartum.

Simple SummaryThe occurrence of early metritis (EM) in dairy cattle causes serious economic losses. The treatment effectiveness for EM is highly controversial. Antibiotics administered by intrauterine infusions have been extensively used to control the growth of aerobic and anaerobic bacteria. Flavonoid glycosides (FGs) are polyphenolic naturally derived compounds considered to have many health-related properties such as antibiotic, anti-inflammatory, phlebotonic, and several vascular-protecting activities. Although FGs have been used for several therapies in humans, there is an increasing interest in investigating PGs for other therapeutic purposes. The objective of the present study was to investigate an alternative treatment for EM based on FG intrauterine infusions during the early postpartum period in dairy cows. FG administration contributed to the onset of uterine and cervix involution, bacteriological and immunological control, and fertility improvement associated with highly dose-specific responses during the early postpartum period in EM-positive dairy cattle.The occurrence of metritis during the postpartum period causes serious economic losses in dairy cattle. The Micronised Purified Flavonoid Fraction (MPFF) is a polyphenolic flavonoid compound which is considered to have many health-related properties such as antibiotic, anti-inflammatory, phlebotonic, and several vascular-protecting activities. The aim was to evaluate the effects of a new strategic therapy for metritis based on MPFF intrauterine infusions during the early postpartum in dairy cows naturally infected by Escherichia coli. The clinical effects on reproductive anatomical structures and chronological involution dynamics were monitored until day 24 postpartum by ultrasonography. Moreover, uterine bacteriological and cytological (polymorphonuclear neutrophils; PMNs) profiles were analysed before and after MPFF infusion. The results showed that the success rate (% cure) at day 24 postpartum was improved significantly when using higher MPFF doses (p < 0.05). Moreover, MPFF treatment acutely diminished the size of the cervix and uterus and improved the involution process during the first 24 days (p < 0.05). The prevalence of pathogenic bacteria found in in vitro cultures was significantly variable (p < 0.01), as were the antibiotic sensitivity patterns. Pathogenic bacteria isolates decreased after MPFF applications in a dose–response fashion (p < 0.01), while isolates obtained from controls and low-dose-MPFF-treated animals were stable and similar (p > 0.05). The sensitivity patterns of pathogenic bacteria isolated in in vitro cultures from MPFF-treated animals were variable, although resistance to E. coli, Staphylococcus aureus, Bacillus spp., and coliforms was shown irrespective of the MPFF doses used. However, MPFF-treated cows showed a dose–response effect regarding PMN rates (p < 0.05). The calving-first service, calving–conception interval, and conception rate improved significantly from using higher MPFF doses (p < 0.05). In conclusion, this study shows that MPFF treatment differentially affects uterine involution, bacteriological profiles, cytological traits, and reproductive performance in metritis-positive dairy cows naturally infected by E. coli.

Exposure to non-esterified fatty acids in vitro results in changes in the ovarian and follicular environment in cattle

Negative energy balance (NEB) in the postpartum period of dairy cows is associated with reduced fertility to insemination later in lactation. We hypothesized that elevated non-esterified fatty acids (NEFA) levels that occur during NEB result in accumulation of fatty acids within the ovarian tissue and preantral follicles, causing changes in ovarian gene expression that would indicate a response to injury. We performed ovarian cortex culture and oocyte maturation in medium containing a combination of palmitic, oleic and stearic acid (NEFA). Ovarian cortex was subjected to RNA sequencing and lipid content analysis via Nile Red staining and gas chromatography; oocytes were analyzed for maturation rate and mitochondrial mass and localization following in vitro maturation (IVM). Accumulation of lipids associated with the plasma membrane was increased in granulosa cells of preantral follicles exposed to NEFA in vitro; RNA sequencing revealed changes in biological functions associated with metabolic disease, stimulation of an inflammatory response, and reduction in glucose uptake. Oocyte maturation under high NEFA compromised nuclear, but not cytoplasmic maturation. These data demonstrate that exposure to NEFA in vitro affects the ovary, preantral follicles and cumulus-oocyte complexes, and provides further insight into the potential links between metabolic imbalance and infertility.

Complementary and Alternative Treatments for Postpartum Uterine Diseases in Dairy Cows

The goal of treating postpartum uterine diseases in dairy cows is to reach clinical cure in a reasonable amount of time and to improve reproductive performance while minimizing milk and meat residue issues. The ultimate goal is to reduce the economic losses caused by uterine diseases. This article focuses on postpartum uterine diseasess in dairy cows, in particular acute puerperal metritis, pyometra and endometritis. The usual treatment approach for these conditions is systemic or local antibiotic therapy to control bacterial growth. Based on clinical signs and bacteria identification using dependent- and independent-based methods, antibiotic use appears to be the most logical and effective therapeutic approach. However, despite considerable research, the treatment of uterine diseasess remains a subject of considerable controversy in the literature. Although some local and systemic antibiotic therapies are effective at mitigating the consequences of postpartum uterine diseases, antibiotic use in the current global context is a serious concern because it is associated with selective pressures on bacteria and the emergence of resistant bacteria in humans and animals. Research on mucosal immunology and the genital microbiota of cows has improved our understanding of uterine involution and how pathological agents behave during uterine diseases in dairy cows. And while antibiotic therapy remains the most common therapeutic option chosen by veterinarian practitioners to treat PUDs, complementary and alternative veterinary medicine is increasingly being considered in response to a demand from animal owners. However, because of the small number of randomized clinical trials and a lack of evidence-based medicine, there is widespread concern regarding the adequacy of evidence for the efficacy and safety of complementary and alternative veterinary medicine. The objectives of this article are to describe uterine involution and the main postpartum uterine diseases that occur during the postpartum period in dairy cows, briefly review the current approaches to treating postpartum uterine diseases, and critically review the evidence pertaining to complementary and alternative veterinary medicine in postpartum reproductive veterinary medicine.

Hepatic effects of rumen-protected branched-chain amino acids with or without propylene glycol supplementation in dairy cows during early lactation

Essential amino acids (EAA) are critical for multiple physiological processes. Branched-chain amino acid (BCAA) supplementation provides energy substrates, promotes protein synthesis, and stimulates insulin secretion in rodents and humans. Most dairy cows face a protein and energy deficit during the first weeks postpartum and utilize body reserves to counteract this shortage. The objective was to evaluate the effect of rumen-protected BCAA (RP-BCAA; 375 g of 27% l-leucine, 85 g of 48% l-isoleucine, and 91 g of 67% l-valine) with or without oral propylene glycol (PG) administration on markers of liver health status, concentrations of nonesterified fatty acids (NEFA) and β-hydroxybutyrate (BHB) in plasma, and liver triglycerides (TG) during the early postpartum period in dairy cows. Multiparous Holstein cows were enrolled in blocks of 3 and randomly assigned to either the control group or 1 of the 2 treatments from calving until 35 d postpartum. The control group (n = 16) received 200 g of dry molasses per cow/d; the RP-BCAA group (n = 14) received RP-BCAA mixed with 200 g of dry molasses per cow/d; the RP-BCAA plus PG (RP-BCAAPG) group (n = 16) received RP-BCAA mixed with 200 g of dry molasses per cow/d, plus 300 mL of PG, once daily from calving until 7 d in milk (DIM). The RP-BCAA and RP-BCAAGP groups, on average (± standard deviation), were predicted to receive a greater supply of metabolizable protein in the form of l-Leu 27.4 ± 3.5 g/d, l-Ile 15.2 ± 1.8 g/d, and l-Val 24.2 ± 2.4 g/d compared with the control cows. Liver biopsies were collected at d 9 ± 4 prepartum and at 5 ± 1 and 21 ± 1 DIM. Blood was sampled 3 times per week from calving until 21 DIM. Milk yield, dry matter intake, NEFA, BHB, EAA blood concentration, serum chemistry, insulin, glucagon, and liver TG and protein abundance of total and phosphorylated branched-chain ketoacid dehydrogenase E1α (p-BCKDH-E1α) were analyzed using repeated measures ANOVA. Cows in the RP-BCAA and RP-BCAAPG groups had lower liver TG and lower activities of aspartate aminotransferase and glutamate dehydrogenase during the first 21 DIM, compared with control. All cows, regardless of treatment, showed an upregulation of p-BCKDH-E1α at d 5 postpartum, compared with levels at 21 d postpartum. Insulin, Met, and Glu blood concentration were greater in RP-BCAA and RP-BCAAPG compared with control during the first 35 DIM. Therefore, the use of RP-BCAA in combination with PG might be a feasible option to reduce hepatic lipidosis in dairy cows during early lactation.

Propionate alleviates palmitic acid–induced endoplasmic reticulum stress by enhancing autophagy in calf hepatic cells

Negative energy balance-induced high blood concentrations of free fatty acids during the early postpartum period in dairy cows is a major cause of liver injury. Cows in severe negative energy balance often have suboptimal intakes of feed, which contributes to shortfalls in production of ruminal propionate and circulating glucose. Although increasing propionate production by the rumen through feed additives such as propylene glycol is effective in helping cows alleviate the shortfall in dietary energy supply, mechanisms whereby propionate affects liver function beyond gluconeogenesis are unknown. Therefore, the objective of this study was to investigate whether propionate could protect calf hepatic cells from palmitic acid (PA)-induced lipotoxicity and the underlying mechanisms. Calf hepatic cells were isolated from 5 healthy calves (1 d old, female, 30-40 kg, fasting) and treated with various concentrations of PA (0, 100, 200, or 400 μM) and propionate (0, 1, 2, or 4 mM) after being administered with or without autophagic inhibitor. Propionate enhanced autophagic activity in calf hepatic cells, as indicated by elevated expression of autophagy markers LC3-II (microtubule-associated protein 1 light chain 3-II, encoded by MAP1LC3) and decreased expression of SQSTM1 (sequestosome-1, also called p62). Conversely, PA suppressed autophagic activity and decreased cell viability, which was improved by propionate in calf hepatic cells. In addition, propionate decreased the phosphorylation of proteins EIF2AK3 (kinase R/PKR like ER kinase) and ERN1 (inositol-requiring enzyme 1α) and cleaved ATF6 (activating transcription factor 6) in PA-treated calf hepatic cells, indicating the suppression effect of propionate on endoplasmic reticulum (ER) stress. However, inhibition of autophagic activity by chloroquine or bafilomycin A1 impede the beneficial effects of propionate on ER stress and cell viability. These results demonstrated that propionate alleviates ER stress and elevates cell viability in PA-treated calf hepatic cells by enhancing autophagy, which implies that autophagy may be a promising target in improving liver injury of dairy cows during transition period.

Interleukins’ expression profile changes in granulosa cells of preovulatory follicles during the postpartum period in dairy cows

The postpartum period in dairy cows is associated with a state of temporary negative energy balance and could induce functional changes into ovarian granulosa cells (GC) resulting in significant impact on the ovarian function and fertility. Yet, the regulation of interleukin receptors (ILRs) in GC as well as ILs expression profile during the postpartum period have not been fully investigated. We hypothesized that the postpartum period is associated with changes in ILs expression profile that could affect follicular development and ovulation rate. First, we aimed to investigate the expression and regulation of different IL and IL receptors in GC at different stages of follicular development and then analyse the changes in target ILs expression profile induced during the postpartum period. In the first objective, normal cycling cows were selected and GC were collected from small follicles (SF), dominant follicles at day 5 of the estrous cycle (DF), and ovulatory follicles, 24 h following hCG injection (OF). In the second objective, dairy cows between 50 and 70 days postpartum were randomly selected, and β-hydroxybutyrate (BHB) concentrations were measured in blood samples in order to assign cows to the BHB+ group (>1.4 mmol/L) or BHB− group (<1.2 mmol/L). GC were collected from preovulatory follicles by transvaginal aspiration. Total RNA was extracted from GC of all groups for analysis of target ILs and ILRs expression. Steady-state mRNA levels of IL4R was strongest in the DF, while IL15R expression was greatest in the OF, and IL21R showed increased steady-state mRNA levels in the corpus luteum as compared to the different groups of follicles. Overall, expression of IL1A, IL1B, IL8, IL15, IL23 and TNFα was stronger in OF as compared to DF, while IL4 and IL10 expression was stronger in SF than in DF. Similarly, expression of IL1A, IL1B, IL8, IL15, IL23, and TNFα were significantly stronger in GC of BHB+ cows than in the control, while IL4 expression was significantly reduced in BHB+ as compared to control cows. We have established an IL expression profile, which suggest a correlation with BHB levels during the postpartum period. Additionally, we have demonstrated a differential regulation of target ILRs in GC at different stages of follicular development. Overall, these data provide a better understanding of the changes that could affect follicular development and ovulation during the postpartum period and lay the ground for further investigations.

Modulation of immune function in the bovine uterus peripartum

There is a high risk of clinical or subclinical reproductive tract disease in the postpartum period in dairy cows. An integrated process of adaptive events should occur synchronously, including a robust but well-regulated immune response in the uterus. Failure of this process may result in reproductive tract inflammatory disease. Up to half of postpartum dairy cows are affected by metritis, purulent vaginal discharge (PVD), or subclinical endometritis. After parturition there is damage to the birth canal, the superficial layer of the endometrium is naturally wounded, and essentially all dairy cows have bacterial contamination in the uterus. Neutrophils are the most abundant type of inflammatory cell and the main line of defence against infection in the uterus. A prompt influx of neutrophils is associated with uterine health. Avoidance of clinical disease (metritis and PVD) depends in large part on how effective the immune response is at limiting the burden and effects of bacterial pathogens, while the occurrence of subclinical endometritis is more a function of avoiding excessive or persistent inflammation. Glucose supply, hypocalcemia, lipid mobilization from body fat, ketosis, and the flux of pro-inflammatory cytokines influence immune response and change rapidly and variably among individual cows. Effective but well-regulated inflammatory response will be favoured by best management practices for transition cows, but specific interventions to modulate immune response to prevent uterine disease remain developmental.

THE EFFECT OF PREPARTUM ANTIOXIDANT ADMINISTRATIONS ON BLOOD BHBA CONCENTRATION IN COWS

Objective: The presented study was aimed that investigation effect of the prepartum antioxidant administration on blood Beta-hydroxybutyric acid ( BHBA) concentrations at day 7th postpartum in Holstein dairy cows. Antioxidants are defined as substances that delay or inhibits oxidative damage . Oxidant s such as reactive oxygen species (ROS) are created as a consequence of adenosine triphosphate (ATP) production in mitochondria. Oxidants can cause tissue damage by damaging cells' macromolecules, such as DNA, proteins, and lipids. Lipids are the most sensitive macromolecule against oxidative damage. Oxidative stress can both disrupt the mechanism of insulin and induce more lipolysis. And so, ROS overproduction can enhance non ‐ esterified fatty acids (NEFA) and BHBA production . Material and Method: Eighty multiparous Holstein breed pregnant dairy cows were used in this study. The cows were divided into two groups as treatment (G1; n=40) and control groups (G2; n=40) . In the G1, solutions containing of vitamins (A, D, E) and trace elements (Cu, Zn, Se, Mn) were performed intramuscularly at 21±5 and 10±5 days before expected parturition (280 days). In the G2, it was performed the same amounts of saline injections as a placebo . Result and Discussion: Blood BHBA levels were found that lower in the G1 group (0.73±0.20 mmol/L) compared to the G2 group (0.84±.29 mmol/L) . In conclusion, it was determined that prepartum antioxidant administrations decrease blood BHBA concentration in the postpartum period in dairy cows.

A model of clinical endometritis in Holstein heifers using pathogenic Escherichia coli and Trueperella pyogenes

Bacterial infection of the uterus causes clinical endometritis in 15 to 20% of postpartum dairy cows and reduces fertility, even after the resolution of disease. However, it is difficult to disentangle the mechanisms linking reduced fertility with endometritis because cows have multiple confounding postpartum conditions. The aim of the present experiment was to develop an in vivo model of clinical endometritis in Holstein heifers using pathogenic Escherichia coli and Trueperella pyogenes. Estrous cycles of heifers were synchronized using a 5-d Co-Synch protocol, and subsequently received exogenous progesterone to elevate circulating progesterone at the time of uterine infusion. Endometrial scarification was performed before uterine infusion of live pathogenic Escherichia coli and Trueperella pyogenes, or sterile vehicle. Effects of infusion were evaluated by measuring rectal temperature, plasma haptoglobin, hematology, grading pus in the vaginal mucus, quantifying 16S rRNA in vaginal mucus, and transrectal ultrasonography. Bacterial infusion increased the median vaginal mucus to grade 2 by d 3 postinfusion, and to grade 3 from d 4 to 6 postinfusion. Control heifers maintained a median vaginal mucus grade ≤1 from d 1 to 6. Transrectal ultrasound revealed the accumulation of echogenic fluid in the uterus of heifers following bacterial infusion, which was absent in control heifers. Total 16S rRNA in vaginal mucus was elevated in bacteria-infused heifers compared with control heifers at d 5. Rectal temperature was increased in bacteria-infused heifers. Plasma haptoglobin, general health, and appetite did not differ between groups. As indicated by increased vaginal mucus grade after bacterial infusion and absence of systemic signs of illness, this model successfully induced symptoms resembling clinical endometritis in virgin Holstein heifers. The model allows the isolation of effects of uterine disease on fertility from confounding factors that can occur during the postpartum period in dairy cows.

Calcium and Magnesium Urinary Excretion in Dairy Cows with Different Fee of Glucose Metabolization

Background: The post-partum period in dairy cows is accompanied by a low glucose metabolism in adipose tissue and skeletal muscle tissue, being glucose conducted to the milk production. In humans, low glucose metabolism is associated with metabolic syndromes, the high glucose levels reduce tubular reabsorption of Magnesium (Mg) and Calcium (Ca), leading to hypomagnesemia and hypocalcemia. These minerals are important to the dairy cow, as their decrease leads to diseases. The aim of this study was to evaluate the relationship between glucose metabolism rate with the urinary excretion of Ca and Mg in multiparous dairy cows during the post-partum period.Materials, Methods &amp; Results: Twenty dairy cows were used from a commercial farm southern Brazil, in the semi-extensive system. Glucose tolerance tests were performed (TTG) on day 9 relative to calving. The cows were categorized into three groups according to the glucose metabolism rate (area under the glucose curve, glucose half-life and glucose consumption rate): High Glucose Metabolization (GA); Intermediate Glucose Metabolizing (GI); and Low Glucose Metabolization (GL). Blood and urine samples were collected on days 0, + 3, + 6, + 9, +16 and +2 3 in relation to calving for to determine the levels of Ca, Mg, insulin (Ins), non-esterified fatty acids (NEFA) and Glu. In urine was evaluated the excretion of Ca and Mg. The cows were milked twice a day (at 3:00 a.m. and 3:00 p.m.) and the milk yield (kg/cow) was recorded daily and averages were generated every five days from day 15 to day 60 postpartum. The statistical analyses were performed with the MIXED procedure to assess the main effect of group, time (in days) and their interaction by using version 9.2 SAS software. The influence of the different rates of glucose metabolism on milk production was observed, the GB group had a production than GH group (30.88 ± 1.44 kg vs 23.96 ± 1.43 kg, P &lt; 0.01), but did not differ from GI. The GL group showed higher levels of Glu compared to GA (P &lt; 0.05). The plasma Ca levels were higher in GL (P &lt; 0.05) compared with GH. The NEFA, insulin, and excretion of minerals did not differ between groups (P &gt; 0.05).Discussion: The low glucose metabolism in humans causes an increase in the excretion of Ca and Mg urine, however, in the animals studied, these changes were not observed. This result can be attributed to the fact that insulin resistance is transitory in dairy cattle. The higher glucose levels in the GL group are related due to the lower capacity of glucose entry in the peripheral tissues (adipose and skeletal muscle), which reflected in the higher milk production observed this group. However, the higher calcium concentrations were not expected, since the release of insulin by β-pancreatic cells is dependent on calcium. Possibly, these higher calcium levels in GB, are related to higher milk production, requiring a greater amount of calcium for the production of casein, increasing bone mobilization, intestinal absorption. The energy metabolites, non-esterified fatty acids and insulin, did not differ between groups, suggesting that the animals did not present different metabolic conditions. We conclude that multiparous dairy cows with low glucose metabolism rate (GB) have higher levels of glucose after delivery and increased milk production. The metabolism rate of glucose did not influence the excretion of the Ca and Mg minerals.

Effects of some diseases observed at postpartum period of cows in dairy farms: Economic perspective

In this study, financial losses due to several endemic diseases at the postpartum period of dairy cows were calculated, using the incidence rates and the financial losses from each clinical case of the endemic diseases reported in the literature. The median values of the incidence rates reported in the literature for retained placenta, clinical hypocalcemia, subclinical hypocalcemia, clinical metritis, clinical mastitis, clinical ketosis, subclinical ketosis, lameness and displaced abomasum were 8.6, 3.9, 33, 13.3, 7, 2.5, 19.8, 4.3 and 1.8% respectively. The average losses per case arising from retained placenta, clinical hypocalcemia, clinical metritis, clinical mastitis, clinical ketosis, lameness and displaced abomasum were calculated to be $257, $279, $278, $212, $109, $223 and $340 respectively. Using the above stated findings, the financial losses for each average cow arising from retainedplacenta, clinical hypocalcemia, clinical metritis, clinical mastitis, clinical ketosis, lameness, displaced abomasum and the total of 7 diseases were estimated to be $22, $11, $37, $15, $3, $9, $6 and $103 respectively.

Lack of effects of an equine chorionic gonadotropin (eCG) administration between days 9 and 15 postpartum on reproductive performance in a Holstein dairy herd

Recently, it has been demonstrated that administration of equine chorionic gonadotropin (eCG) in the postpartum period in dairy cows can enhance follicle growth, reduce the interval from calving to first ovulation and increase plasma estradiol concentrations, and, thus, could enhance reproductive performance in a dairy herd when administered on day 6 postpartum. The aim of this study was to investigate the effects of a single dose of eCG between days 9 and 15 postpartum on parameters of reproductive performance in dairy cows. German Holstein cows (n=1937; primiparous cows: n=748; pluriparous cows: n=1189) in a commercial dairy farm were randomly assigned to three experimental groups. Animals within the group eCG received a single dose of 600 IU eCG intramuscularly (i.m.) between days 9 and 15 postpartum followed by an i.m. administration of 500 μg cloprostenol after 14days. Those of treatment group PG received cloprostenol only between days 23 and 29 postpartum. Cows of the control group remained untreated. Starting on day 49 postpartum, cows were subjected to a Presynch-Ovsynch protocol and inseminated artificially. The impact of application time (days postpartum) of eCG on the intervals calving to first service and calving to conception was statistically not significant. Outcomes of reproductive performance (i.e. first service conception rate, proportion of pregnant cows until 100 and 150days in milk [DIM], number of inseminations until 150 DIM, calving to first service interval and calving to conception interval) did not differ significantly between treatment group eCG and group PG compared to control group. Regarding postpartum eCG administration, significant interactions between treatment and parity, season, milk yield, and early puerperal disorders, respectively, could not be shown. In conclusion, an eCG treatment of dairy cows between days 9 and 15 postpartum to increase reproductive performance cannot be recommended under the given circumstances.

Rumen protected branched amino acids supplementation during early lactation in dairy cows

The objective of this study was to test if supplementation of Rumen Protected Branched-Chain Amino Acids (RPBCAA) with or without PG oral supplementation improved milk protein yield as well as negative energy balance during the early postpartum period in dairy cows.

Factors associated with ovarian structures and intrauterine fluid in the postpartum period in dairy cows

The objective was to examine risk factors for the interval to resumption of ovarian cyclicity (ROC), multiple ovulations (MCL), ovarian follicular cysts (OC), and presence of intrauterine fluid (IUF) at 22 to 28 [visit (V) 1] and 36 to 42 (V2) days in milk (DIM) in dairy cows. The study was conducted retrospectively by evaluating records from 1,155 Holstein cows from 3 herds. Ovaries and uteri were examined at V1 and V2 by transrectal ultrasonography to determine ovarian structures and IUF. Based on the odds ratio, multiparous cows were more likely to have ROC at V1 by a factor of 1.79 compared with primiparous cows. The likelihood of ROC at V1 was lower in cows with higher milk production, in cows with retained fetal membranes (RFM) or cows with IUF at V1 by factors of 0.98 (for each kg of milk increased), 0.52, and 0.61, respectively. Based on the odds ratio, cows diagnosed with IUF at V2 were 2.85 times more likely to have attained ROC at V2. Multiparous cows and cows that delivered twins were 2.73 and 2.16 times, respectively, more likely to have MCL at V1, whereas cows with RFM were 0.38 times less likely to have MCL at V1. The likelihood of MCL at V2 was higher in cows with MCL and OC at V1 by factors of 2.67 and 1.91, respectively. Multiparous cows were 8.51 times more likely to have OC at V1 than primiparous cows. Higher producing cows were more likely to have OC at V2 by a factor of 1.04 compared with lower producing cows. Parity, stillbirth, RFM, and ROC at V1 were all identified as risk factors for IUF at V1. Cows with RFM and delivering twins were more likely to be diagnosed with IUF at V2 by a factor of 3.43 and 4.07, respectively. In summary, parity, twinning, RFM, metritis, IUF, and milk production were all associated with altered ovarian structures, and the presence of IUF was related to parity, twinning, RFM, and ROC in postpartum dairy cows.

Short communication: Oxidative status and incidence of mastitis relative to blood α-tocopherol concentrations in the postpartum period in dairy cows

Vitamin E supplementation, when combined with high blood α-tocopherol (>6.25μg/mL) at dry off, has been reported to unexpectedly increased the risk for clinical mastitis in dairy cows. Furthermore, higher levels of oxidative stress in the postpartum period were related to higher risk of mastitis. The objective of the present study was to determine the relationship between various serum biomarkers of oxidative status, incidence of mastitis, and blood α-tocopherol concentrations at dry off and at calving. A total of 146 dairy cows from a commercial farm were used in an observational field study. All cows were supplemented with 3,000 and 50IU/cow per day of all-rac-α-tocopherol during the dry period and lactation, respectively. Blood samples were collected at dry off and at calving. Serum was analyzed for α-tocopherol, levels of reactive oxygen metabolites (ROM), thiol groups (SH), and ferric-reducing ability. Three α-tocopherol groups at calving were created: high (>3μg/mL), medium (2–3μg/mL), and low (<2μg/mL). Three α-tocopherol groups at dry off were created: high (>6.25μg/mL), medium (4.25–6.25μg/mL), and low (<4.25μg/mL). All cases of clinical mastitis that occurred during the dry period and the entire subsequent lactation were verified by a veterinarian. No differences were observed in the incidence of mastitis between the 3 α-tocopherol groups based on the serum levels at dry off. Incidence of mastitis was 4 times lower in the high and medium groups when compared with the corresponding value for the low-α-tocopherol group based on the serum levels at calving. Lower levels of ROM and SH at dry off and at calving were found in the group of cows with the highest α-tocopherol values at dry off when compared with the corresponding values in the low-α-tocopherol group. The ROM values at dry off but not at calving were lower in the group of cows with the highest α-tocopherol values at calving when compared with the corresponding values in the low-α-tocopherol group. No differences were observed in ferric-reducing ability values between the 3 α-tocopherol groups at dry off or calving. No differences were observed in all biomarkers of oxidative status between healthy cows and those with mastitis. Thus, blood α-tocopherol is inversely related to certain biomarkers of oxidative stress in the postpartum period and incidence of mastitis. However, reduction in the incidence of mastitis is not mediated through a reduction in the levels of various biomarkers of oxidative stress.

Increased preconception omega-3 polyunsaturated fatty acid intake improves embryo morphology

The association between preconception dietary intake of the polyunsaturated fatty acids (LC-PUFAs) omega-6 and omega-3 and the E(2) levels and IVF/intracytoplasmic sperm injection (ICSI) outcome were investigated in women in a prospective study. It revealed that high intakes of omega-3 LC-PUFA alpha-linolenic acid increase baseline E(2), high intakes of eicosapentaenoic acid and docosahexaenoic acid reduce E(2) response and the number of follicles after ovarian stimulation, and total omega-3 intake, in particular alpha-linolenic acid and docosahexaenoic acid, improve embryo morphology.

The evaluation of postpartum period in dairy cows with normal and periparturient problems

The evaluation of uterine diameter, bacterial flora, ovarian activity and fertility parameters was aimed in this study by means of clinical examination performed 20, 30 and 40 days after calving in dairy cows exhibiting normal (Group 1, n=30) and abnormal (Group 2, n=30) periparturient periods. On the 20th, 30th and 40th day postpartum; in Group 2, uterine horns had larger diameters compared to Group 1. In both groups, the rate of involution was determined to be higher between 20 and 30 days postpartum in previously gravid uterine horns, and between 30 and 40 days postpartum in non-gravid uterine horns. In Group 2, fluid accumulation in both uterine horns was determined to be high on the 20th and 30th day postpartum. Bacterial agents were isolated from 11 and 25 cows in Groups 1 and 2, respectively on the 20th day after calving. The most frequently found microorganisms were determined to be E. coli in the first and A. pyogenes in the second group. However an evident reduction in the number of bacteria was observed in the second group on the 40th day after calving. Among the animals included in Group 1, 10 were determined to have regular ovarian activity, 12 to have inactive ovaries, 2 to have resistant luteal structures, and 6 to have resistant follicular structures throughout the 40 days following calving. The numbers of animals in Group 2 detected to exhibit the same structures were determined as 7, 16, 4 and 3 cows, respectively. The interval from calving to the first service and the calving to conception interval were found to be prolonged in Group 2. The high level of fluid accumulation in the uterus, especially between days 20-30 postpartum, the difference between measurements of previously gravid uterine horns and the isolation of A. pyogenes were regarded as parallel findings.

Endometrial expression of the insulin-like growth factor system during uterine involution in the postpartum dairy cow

Rapid uterine involution in the postpartum period of dairy cows is important to achieve a short interval to conception. Expression patterns for members of the insulin-like growth factor (IGF) family were determined by in situ hybridisation at day 14±0.4 postpartum (n=12 cows) to investigate a potential role for IGFs in modulating uterine involution. Expression in each uterine tissue region was measured as optical density units and data were analysed according to region and horn. IGF-I mRNA was localized to the sub-epithelial stroma (SES) of inter-caruncular and caruncular endometrium. Both IGF-II and IGF-1R expression was detected in the deep endometrial stroma (DES), the caruncular stroma and myometrium. IGFBP-2, IGFBP-4 and IGFBP-6 mRNAs were all localised to the SES of inter-caruncular and caruncular uterine tissue, and in the DES and caruncular stroma, with IGFBP-4 mRNA additionally expressed in myometrium. IGFBP-3 mRNA was only detectable in luminal epithelium. IGFBP-5 mRNA was found in myometrium, inter-caruncular and caruncular SES and caruncular stroma. These data support a role for IGF-I and IGF-II in the extensive tissue remodelling and repair which the postpartum uterus undergoes to return to its non-pregnant state. The differential expression of binding proteins between tissues (IGFBP-3 in epithelium, IGFBP-2, -4, -5 and -6 in stroma and IGFBP-4 and -5 in myometrium) suggest tight control of IGF activity within each compartment. Differential expression of many members of the IGF family between the significantly larger previously gravid horn and the previously non-gravid horn may relate to differences in their rate of tissue remodelling.